Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03440827
Other study ID # RC31/17/0210
Secondary ID 2017-A01881-52
Status Recruiting
Phase N/A
First received February 14, 2018
Last updated March 2, 2018
Start date February 23, 2018
Est. completion date February 2019

Study information

Verified date March 2018
Source University Hospital, Toulouse
Contact Juliette Mazereeuw-Hautier, MD
Phone 5 67 77 81 41
Email mazereeuw-hautier.j@chu-toulouse.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The low-flow malformations include venous and lymphatic malformations. The malformation often affects the skin and can extend deep to the muscles and bone, as well as to deep organs. Children with low-flow vascular malformation and their family have difficulty living with their illness and have an impact on their life quality.

In this context, the aim of the study is to develope life quality test for the children between 11 to 15 years old.


Description:

The low-flow vascular malformations include venous and lymphatic malformations. These malformations are made of dilated dysplastic vessels in which the circulation is lowed down, which can lead to phenomena of thrombosis, hemorrhage, with sometimes a repercussion on the general coagulation. The malformation often affects the skin and can extend deep to the muscles and bone, as well as to deep organs. It presents by swelling sometimes voluminous and often painful. Children with low-flow malformations and their families have difficulty living with their illness and have an impact on their quality of life (QOL).

These difficulties seem relative to :

- the lack of knowledge of the disease by doctors and the general public - medical difficulties directly related to the disease and its evolution: pain, deformation, biological anomaly, chronicity, lack of effective treatment

- psychological difficulties related to the visible and unesthetic appearance of the lesions

- excluding certain social activities The difficulties experienced by patients with slow-flow malformations and their family, as well as the impact on their QOL, have never been studied. Although QOL appears to be the best reflection of the severity of a chronic condition, there is no QOL questionnaire that is appropriate for the slow-flow malformations of the child or adult.

The aim of the study is to develope a specific life quality test for children between 11 to 15 years old.

These data will be used in a second time to build and validate a scale of quality of life specific slow-flow malformations of the child aged 11 to 15 years old. The study is build in 3 parts:

Focus group: collect the dimension of the lived experience and the perceptions of the children with slow-flow malformations as well as their needs and their expectations

Validation of the life quality test: the data obtained during focus group will be used to develop the scale of life quality specific to the child aged 11 to 15 years suffering to low-flow malformations. In a second time to validate the scale, this life quality test will be send to patients.


Recruitment information / eligibility

Status Recruiting
Enrollment 300
Est. completion date February 2019
Est. primary completion date February 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 11 Years to 15 Years
Eligibility Inclusion Criteria:

Phase 1:

- Patient with slow-flow vascular malformation, regardless of clinical form, severity (clinical and imaging diagnosis), aged 11 to 15 years-old.

- Patient with slow-flow vascular malformation, whatever its clinical form, its severity (clinical and imaging diagnosis), aged over 15 years-old.

- Parents of a patient with slow-flow vascular malformation, regardless of clinical form, severity (clinical and imaging diagnosis), aged 11 to 15 years-old inclusive

- Patient affiliated to a social security scheme

- Patient having given his consent or for the minor whose legal representative has given written informed consent.

Phase 2 :

- Patient with slow-flow vascular malformation, regardless of clinical form, severity (clinical and imaging diagnosis), 11 to 15 years-old of age included.

- Patient affiliated to a social security scheme

- Patient having given his consent or for the minor whose legal representative has given his informed consent

Exclusion criteria :

For both phases: Pregnant or lactating women or girls,

- Vulnerable persons,

- Majors subject to a legal protection measure or unable to express their consent Phase 1: Patient or parent who does not speak the French language and therefore are unable to express themselves in the focus groups.

- Patient under 11 years-old; Phase 2 : Patient who does not speak French and is therefore unable to complete quality of life questionnaires

- Patient under 11 or over 15 years-old.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Focus Group
First (phase 1), collect experiences, perceptions, difficulties, needs and expectations of patients with slow-flow malformations (for the age group of 11 to 15 years-old), carried out with 3 categories of participants and then (phase 2) development and validation of the specific scale of life's quality of slow-flow vascular malformation in children aged 11 to 15 years-old.

Locations

Country Name City State
France UHBordeaux Bordeaux
France UHChambray Chambray-lès-Tours
France UHNantes Nantes

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Toulouse

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Specific scale of life's quality for slow-flow vascular malformation Specific scale of life's quality for slow-flow vascular malformation.
the preliminary version of which is created by transforming the qualitative categories resulting from the qualitative analysis of the verbatim into an exhaustive list of thematic items which will then be selected and sorted by the experts
and whose final version is obtained by the statistical validation analysis aimed at structural validity and unidimensionality and convergent and discriminant validity.
12 months
See also
  Status Clinical Trial Phase
Completed NCT02561182 - Bone Health in Patients With Overgrowth
Completed NCT02384122 - Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias Phase 3
Active, not recruiting NCT03987152 - Treatment of Congenital Vascular Malformations Using Sirolimus: Improving Quality of Life Phase 3
Recruiting NCT05113420 - The Efficacy and Safety of Different Phlebotonic Drugs in Children With Venous Malformations
Recruiting NCT06189092 - Treatment of Low-flow Venous Malformations With Electrosclerotherapy. Prospective Observational Study
Completed NCT04637997 - Influence of Flat-knitted Compression Stockings Class I and II on Venous Malformations N/A
Recruiting NCT02883023 - Electrosclerotherapy for Capillary Malformations Phase 2
Recruiting NCT06160739 - Role of Sirolimus in Treatment of Microcystic , Mixed Lymphatic and Vascular Malformations
Completed NCT02991352 - Stereotactic MRI Based Image Guidance for the Treatment of Vascular Malformations - a Pilot Study N/A
Recruiting NCT03972592 - Topical Sirolimus in Cutaneous Lymphatic Malformations Phase 2
Active, not recruiting NCT05418816 - SelfWrap-Assisted Arteriovenous Fistulas N/A
Recruiting NCT04104464 - Patient Reported Outcomes for Vascular Malformations EmbolizatioN (PROVEN)
Recruiting NCT02638389 - Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard Care Phase 3
Recruiting NCT05563831 - National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
Completed NCT00577213 - Diagnosis of Hemangiomas and Vascular Malformations N/A
Recruiting NCT05494710 - Bleomycin Electrosclerotherapy Treatment of Vascular Malformations: A Feasibility Study N/A
Enrolling by invitation NCT06399367 - Investigation of Lipedema, Lymphedema and Vascular Malformations by Multispectral Optoacoustic Tomography (MSOT)
Completed NCT01576601 - The Management of Postoperative Craniotomy Pain in Pediatric Patients N/A
Completed NCT04836884 - Vascular Anomaly Pathology and Genomics Biopsy Study N/A
Not yet recruiting NCT05983159 - A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations Phase 2